Loading...

Natera, Inc.

NTRANASDAQ
Healthcare
Medical - Diagnostics & Research
$138.13
$-2.95(-2.09%)

Natera, Inc. (NTRA) Stock Overview

Explore Natera, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B+

Score: 72.5/100

Key Financials

Market Cap20.7B
P/E Ratio-109.44
EPS (TTM)$-1.47
ROE-0.18%
Fundamental Analysis

AI Price Forecasts

1 Week$169.65
1 Month$164.98
3 Months$190.36
1 Year Target$270.10

NTRA Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Natera, Inc. (NTRA) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 56.88, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $270.10.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -109.44 and a market capitalization of 20.7B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;